Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Cosmet Sci ; 33(2): 190-6, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21272037

RESUMO

Preservation using combinations of preservatives has several advantages. This study shows that the concentration of some of the most frequently used allergenic preservatives can be markedly lowered when they are combined with phenoxyethanol. The antimicrobial efficacy of cosmetic preservatives and known allergens of various potency [diazolidinyl urea, methylchloroisothiazolinone/methylisothiazolinone (MCI/MI), methylisothiazolinone (MI) and phenoxyethanol] was tested alone and in various combinations of two or three preservatives together. The preservatives were tested for minimum inhibitory concentration (MIC) values and possible synergy using fractional inhibitory concentration. MCI/MI was the only preservative showing low-level MIC against all four tested microorganisms: Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger. Different combinations of the preservatives indicated additive effects against the microorganisms. No combination of preservatives showed any inhibitory action on each other. Challenge tests with different concentrations and combinations were performed in a cosmetic cream. Diazolidinyl urea and MCI/MI alone were ineffective against C. albicans in a challenge test at concentrations up to 16 times higher than the observed MIC values. When combining phenoxyethanol with either one of the allergenic preservatives diazolidinyl urea, MCI/MI or MI, the cosmetic cream was adequately preserved at concentrations well below the preservatives' MIC values as well as 10-20 times below the maximum permitted concentrations. By using combinations of preservatives, effective preservation can be achieved with lower concentrations of allergenic preservatives.


Assuntos
Anti-Infecciosos/farmacologia , Cosméticos/farmacologia , Conservantes Farmacêuticos/farmacologia , Candida albicans/efeitos dos fármacos , Cosméticos/química , Humanos , Testes de Sensibilidade Microbiana , Pseudomonas aeruginosa/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos
2.
J Neuroendocrinol ; 15(3): 250-5, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12588513

RESUMO

This study investigated whether pituicytes were able to produce and release nitric oxide (NO), and which type of nitric oxide synthase (NOS) would be responsible for this phenomenon. Lipopolysaccharide (LPS) 1 micro g/ml was used as inflammatory mediator. Because pituicytes are known to secrete interleukin (IL)-6 upon stimulation with LPS, this parameter was also investigated. Cultured pituicytes, from 4-week-old male mice, were stimulated with LPS for 6 h or 24 h. At 24 h, there was a significant increase in accumulated nitrite indicating NO formation. In contrast, IL-6 release was already significantly higher 6 h after stimulation and further increased at 24 h. The correlation between accumulated nitrite and secreted IL-6 was 0.84 after 24 h of incubation with LPS. The expression of inducible NOS (iNOS) mRNA in the pituicytes was significantly higher than the control level after 6 h and 24 h of exposure to LPS, with levels at 6 h being significantly higher than those at 24 h. There was no detected expression of endothelial NOS or neuronal NOS mRNA. Cultured pituicytes were also subjected to immunocytochemistry for iNOS protein at 6, 12, and 24 h after stimulation with LPS. Most cells were positive for iNOS, but there were no observable differences with the time points that we used. Collectively, these results show that pituicytes are able to produce NO, and that the inducible form of NOS is responsible for this production. Furthermore, there is a weak correlation between NO and IL-6 released from pituicytes after 24 h of stimulation with LPS.


Assuntos
Óxido Nítrico Sintase/metabolismo , Óxido Nítrico/metabolismo , Neuro-Hipófise/enzimologia , Animais , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Proteína Glial Fibrilar Ácida/análise , Mediadores da Inflamação/metabolismo , Interleucina-6/metabolismo , Lipopolissacarídeos/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos ICR , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo I , Óxido Nítrico Sintase Tipo II , Óxido Nítrico Sintase Tipo III , Nitritos/metabolismo , Neuro-Hipófise/citologia , Neuro-Hipófise/imunologia , RNA Mensageiro/análise
3.
J Clin Pharm Ther ; 25(4): 283-9, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10971779

RESUMO

BACKGROUND: Pharmaceutical products containing proteins cause problems in testing for endotoxin and pyrogens. Many proteins interfere with the LAL test and the proteins are immunogenic in rabbits. The monocytic cell line Mono Mac 6 is an alternative assay for detection of endotoxin and other pyrogens. OBJECTIVE: To evaluate the use of the Mono Mac 6 assay for quantitative detection of endotoxin in proteins. METHOD: The quantitative detection of endotoxin in the three pharmaceutical products human albumin, gamma-globulin and somatropin was evaluated. RESULTS: For the three proteins the detection limit of the Mono Mac 6 assay was far below the threshold endotoxin limit described by the European Pharmacopoeia. Interference of two of the proteins with the Mono Mac 6 assay was observed, but the problems could be overcome either by dilution of the product or by comparison of the test with an endotoxin standard curve prepared in a solution of the respective pyrogen-free protein. CONCLUSION: The Mono Mac 6 assay is a reliable method for quantitative detection of endotoxin in proteins.


Assuntos
Contaminação de Medicamentos , Endotoxinas/análise , Monócitos/fisiologia , Preparações Farmacêuticas/normas , Administração Oral , Animais , Bioensaio/métodos , Linhagem Celular , Humanos , Monócitos/citologia , Proteínas , Coelhos , Sensibilidade e Especificidade
4.
Eur J Pharm Sci ; 11(1): 51-7, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10913753

RESUMO

The monocytic cell line Mono Mac 6 is sensitive to pyrogens. When exposed to pyrogens secretion of interleukin-6 is induced. However, some eukaryotic pyrogenic microorganisms are not detectable. The aim of this study is to introduce a pretreatment of samples to expand the detection range of the assay. The interleukin-6 inducing capacity of a broad spectrum of UV-killed and ultrasonicated microorganisms is examined in Mono Mac 6 cells. The interleukin-6 secretion is determined in a sandwich immunoassay (DELFIA). The Mono Mac 6 assay is able to detect UV-killed Bacillus subtilis, Staphylococcus aureus and Salmonella typhimurium, but neither Candida albicans nor Aspergillus niger. After ultrasonication of the microorganisms it is possible to detect C. albicans and A. niger. The interleukin-6 inducing ability of the examined microorganisms is in no case reduced after ultrasonic treatment. However, ultrasonication of S. aureus results in a 100-fold increase in the interleukin-6 response. Even after ultrasonication Streptococcus faecalis can not be detected. Ultrasonication is an easy and simple method for expanding the detection range in the Mono Mac 6 assay.


Assuntos
Candida albicans/química , Bactérias Gram-Negativas/química , Bactérias Gram-Positivas/química , Interleucina-6/metabolismo , Monócitos/microbiologia , Sonicação , Linhagem Celular , Humanos , Monócitos/citologia , Monócitos/efeitos dos fármacos , Pirogênios/química , Pirogênios/farmacologia
5.
Int J Pharm ; 191(2): 141-9, 1999 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-10564840

RESUMO

Pyrogen induced secretion of interleukin 6 (IL-6) in Mono Mac 6 (MM6) cells was measured. The ability of the MM6 cell culture to detect pyrogens was compared to the Limulus amoebocyte lysate (LAL) test and isolated mononuclear cells (MNC). The detection limit of MM6 for lipopolysaccharide (LPS) and Staphylococcus aureus was comparable to that of MNC. Aspergillus niger and Candida albicans induced IL-6 in isolated MNC, but not in MM6. The detection limit for Salmonella typhimurium in the MM6 assay was comparable to that of the LAL assay. As expected, S. aureus and C. albicans did not show any LAL activity. A. niger and Influenza virus showed some activity in the LAL test, but could not be detected by MM6 cells. In conclusion, the MM6 assay is a good supplement to the current pyrogen assays for detection of LPS, S. aureus and S. typhimurium, but the MM6 assay could not detect A. niger, C. albicans and Influenza virus.


Assuntos
Teste do Limulus , Monócitos/efeitos dos fármacos , Pirogênios/farmacologia , Bioensaio , Linhagem Celular , Humanos , Imunoensaio , Técnicas In Vitro , Indicadores e Reagentes , Interleucina-6/metabolismo , Cinética , Lipopolissacarídeos/farmacologia , Monócitos/metabolismo , Estimulação Química , Fator de Necrose Tumoral alfa/metabolismo
6.
Eur J Pharmacol ; 378(1): 143-8, 1999 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-10478575

RESUMO

In this study, we examined the effect of adrenaline and interleukin-1beta on interleukin-6 secretion from cultured murine neurohypophyseal cells. Cells were cultured from neurohypophyses of 3- to 5-week-old mice and experiments were performed after 13 days in culture. Interleukin-6 was measured in 24-h samples using a sandwich fluoroimmunoassay. Unstimulated cells released 19+/-3 fmol interleukin-6/neurohypophysis/24 h (mean +/- S.E.M., n = 42). Adrenaline and interleukin-1beta increased the release of interleukin-6 from the cells in a concentration-dependent manner. Incubation with adrenaline (10(-6) M) or interleukin-1beta (11 pM) induced maximal secretion of interleukin-6, resulting in a 2.2-fold and 19.8-fold increase, respectively (P<0.01). The action of adrenaline (10(-6) M) and interleukin-1beta (1.1 pM) was examined separately and together. The sum of the effect of the two compounds given alone was significantly less (P<0.05) than the effect when adrenaline and interleukin-1beta were given together. We examined the effect of the beta-adrenoceptor antagonist propranolol (3.4x10(-6) M), the beta2-adrenoceptor antagonist (+/-)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methyl-eth yl)amino]-2-butanol (ICI 118551) (10(-7) M) and the beta1-adrenoceptor antagonist atenolol (10(-7) M and 10(-6) M) on the adrenaline-stimulated release of interleukin-6. Propranolol and ICI 118551 completely blocked the action of adrenaline, whereas atenolol was inactive. It is concluded that the stimulatory effect of adrenaline is mediated via beta2-adrenoceptors.


Assuntos
Epinefrina/farmacologia , Interleucina-6/metabolismo , Neuro-Hipófise/efeitos dos fármacos , Receptores Adrenérgicos beta 2/metabolismo , Antagonistas Adrenérgicos beta/farmacologia , Animais , Atenolol/farmacologia , Células Cultivadas , Interações Medicamentosas , Interleucina-1/metabolismo , Camundongos , Neuro-Hipófise/citologia , Neuro-Hipófise/metabolismo , Propanolaminas/farmacologia , Propranolol/farmacologia
7.
J Clin Pharm Ther ; 22(5-6): 327-33, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-19160716

RESUMO

OBJECTIVE: Measurement of lipopolysaccharide (LPS) induced interleukin-6 (IL-6) secretion in Mono Mac 6 cells. METHOD: Dissociation-enhanced lanthanide fluoro immunoassay (DELFIA), a technique based on time-resolved fluorescence. RESULTS: A comparison of DELFIA and the B9 bioassay showed a correlation between the results of the two assays. DELFIA did not show any crossreactivity with the human cytokines TNFalpha, IL-1beta, IL-1alpha, IL-2, IL-4, IFNgamma, murine IL-6 or LPS. In aqueous solution the detection limit was 2.5 pg LPS/ml, and in a 25% dilution of a lipid-based total parenteral nutrition (TPN) product it was 25 pg LPS/ml. TPN did not interfere with the DELFIA assay, but the IL-6 secretion from the Mono Mac 6 cells was inhibited at TPN concentrations above 25%. CONCLUSION: A combination of Mono Mac 6 cells with DELFIA was found to be a reliable method for detecting LPS, but further validation by independent laboratories is justified.


Assuntos
Contaminação de Medicamentos , Lipopolissacarídeos/análise , Monócitos/química , Nutrição Parenteral Total , Pirogênios/análise , Bioensaio , Linhagem Celular , Reações Cruzadas , Európio , Fluorimunoensaio/métodos , Humanos , Indicadores e Reagentes , Interleucina-6/análise , Controle de Qualidade
8.
Biochemistry ; 34(33): 10319-24, 1995 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-7654685

RESUMO

The alphavirus Semliki Forest virus (SFV) enters cells through receptor-mediated endocytosis. Subsequently, triggered by the acid pH in endosomes, the viral envelope fuses with the endosomal membrane. Membrane fusion of SFV has been shown previously to be dependent on the presence of cholesterol in the target membrane. Recently, we have demonstrated that fusion of SFV also requires sphingolipids [Nieva, J. L., Bron, R., Corver, J., & Wilschut, J. (1994) EMBO J. 13, 2797-2804]. In the present paper, we show that the activation of low-pH-dependent fusion of SFV by sphingolipids is a stereospecific process. Pyrene-labeled SFV fused rapidly and extensively with liposomes consisting of a mixture of phosphatidylcholine, phosphatidylethanolamine, and cholesterol, supplemented with low concentrations of D-erythro-ceramide, representing the naturally occurring sphingolipid stereoisomer. Fusion was assessed by a decrease in the pyrene excimer fluorescence. L-erythro-, D-threo-, and L-threo-ceramide did not support fusion of the virus. Similar results were obtained with the corresponding sphingomyelin stereoisomers. The stereospecificity of SFV fusion activation was confirmed by using an assay based on degradation of the viral capsid protein by trypsin encapsulated in the target liposomes. Fusion mediated by D-erythro-ceramide was not affected by the additional presence in the target liposomes of ceramide stereoisomers incapable of fusion activation. Binding of the virus to the liposomes, as assessed by flotation on sucrose density gradients, was not dependent on the presence of fusion-competent or fusion-incompetent sphingolipids in the liposomes. The results of this study support the notion that a stereospecific interaction of the viral fusion protein with D-erythro sphingolipids in the target membrane represents an essential step in the activation of the fusion capacity of SFV.


Assuntos
Fusão de Membrana/efeitos dos fármacos , Vírus da Floresta de Semliki/fisiologia , Esfingolipídeos/farmacologia , Ceramidas/química , Ceramidas/farmacologia , Colesterol/metabolismo , Corantes Fluorescentes , Concentração de Íons de Hidrogênio , Lipossomos/metabolismo , Fosfatidilcolinas/metabolismo , Fosfatidiletanolaminas/metabolismo , Pirenos , Vírus da Floresta de Semliki/ultraestrutura , Esfingomielinas/química , Esfingomielinas/farmacologia , Estereoisomerismo
9.
J Virol ; 69(5): 3220-3, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7707555

RESUMO

Low-pH-induced membrane fusion of Semliki Forest virus (SFV) in a model system is mediated by sphingolipids in the target membrane; ceramide is the sphingolipid minimally required (J. L. Nieva, R. Bron, J. Corver, and J. Wilschut, EMBO J. 13:2797-2804, 1994). Here, using various ceramide analogs, we demonstrate that sphingolipid-dependent fusion of SFV with cholesterol-containing liposomes exhibits remarkable molecular specificity, the 3-hydroxyl group and the 4,5-trans carbon-carbon double bond of the sphingosine backbone being critical for the sphingolipid to mediate the process. This observation supports the notion that sphingolipids act as a cofactor in SFV fusion, interacting directly with the viral fusion protein to induce its ultimate fusion-active conformation.


Assuntos
Fusão de Membrana/fisiologia , Vírus da Floresta de Semliki/fisiologia , Esfingolipídeos/fisiologia , Ceramidas/química , Ceramidas/fisiologia , Colesterol/química , Concentração de Íons de Hidrogênio , Hidroxilação , Lipossomos/química , Modelos Biológicos , Estrutura Molecular , Conformação Proteica , Esfingolipídeos/química , Proteínas Virais de Fusão/química , Proteínas Virais de Fusão/fisiologia
10.
Mol Membr Biol ; 12(1): 143-9, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7767374

RESUMO

Semliki Forest virus (SFV) utilizes a membrane fusion strategy to introduce its genome into the host cell. After binding to cell-surface receptors, virus particles are internalized through receptor-mediated endocytosis and directed to the endosomal cell compartment. Subsequently, triggered by the acid pH in the lumen of the endosomes, the viral envelope fuses with the endosomal membrane. As a result of this fusion reaction the viral RNA gains access to the cell cytosol. Low-pH-induced fusion of SFV, in model systems as well as in cells, has been demonstrated previously to be strictly dependent on the presence of cholesterol in the target membrane. In this paper, we show that fusion of SFV with cholesterol-containing liposomes depends on sphingomyelin (SM) or other sphingolipids in the target membrane, ceramide representing the sphingolipid minimally required for mediating the process. The action of the sphingolipid is confined to the actual fusion event, cholesterol being necessary and sufficient for low-pH-dependent binding of the virus to target membranes. The 3-hydroxyl group on the sphingosine backbone plays a key role in the SFV fusion reaction, since 3-deoxy-sphingomyelin does not support the process. This, and the remarkably low levels of sphingolipid required for half-maximal fusion (1-2 mol%), suggest that the sphingolipid does not play a structural role in SFV fusion, but rather acts as a cofactor, possibly through activation of the viral fusion protein. Domain formation between cholesterol and sphingolipid, although it may facilitate SFV fusion, is unlikely to play a crucial role in the process.


Assuntos
Colesterol/química , Lipossomos/química , Vírus da Floresta de Semliki/metabolismo , Esfingolipídeos/química , Esfingolipídeos/farmacologia , Animais , Membrana Celular/metabolismo , Ceramidas/farmacologia , Colesterol/metabolismo , Colesterol/farmacologia , Gema de Ovo/química , Fluorescência , Concentração de Íons de Hidrogênio , Cinética , Lipossomos/metabolismo , Camundongos , Pirenos , Esfingomielinas/farmacologia , Esfingosina/química , Esfingosina/farmacologia , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...